Skip to main content
SpringerLink
Log in

Keine Dauertherapie

Medikamente gegen Schwindel

Drug treatment for dizziness

  • FORTBILDUNG
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Die Therapie der Schwindelsymptomatik orientiert sich primär an der Ursache. In bestimmten Fällen können Antivertiginosa eingesetzt werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin. Akuter Schwindel in der Hausarztpraxis (S3-Leitlinie). AWMF-Register-Nr. 053-018, gültig bis 31. August 2019

  2. Cirek Z, Schwarz M, Baumann W, Novotny M. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate versus betahistine in the treatment of otogenic vertigo: a double-blind, randomised clinical study. Clin Drug Investig. 2005;25:377–89

    Article  CAS  Google Scholar 

  3. Hahn A, Sejna I, Stefflova B et al. A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders: a randomized, reference-controlled clinical study. Clin Drug Investig. 2008;28:89–99

    Article  CAS  Google Scholar 

  4. Scholtz AW, Schwarz M, Baumann W et al. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study. Clin Ther. 2004;26:866–77

    Article  CAS  Google Scholar 

  5. Oosterveld WJ. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study. J Laryngol Otol. 1984;98:37–41

    Article  CAS  Google Scholar 

  6. Pytel J, Nagy G, Tóth A et al. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study. Clin Ther. 2007;29:84–98

    Article  CAS  Google Scholar 

  7. Albera R, Ciuffolotti R, Di Cicco M et al. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol. 2003;123:588–93

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik III für Innere Medizin der Universität zu Köln, Kerpener Str. 62, D-50937, Köln, Deutschland

    Christopher Hohmann,  Roman Pfister &  Guido Michels

Authors
  1. Christopher Hohmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roman Pfister
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guido Michels
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guido Michels.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hohmann, C., Pfister, R. & Michels, G. Medikamente gegen Schwindel. MMW - Fortschritte der Medizin 160, 50–52 (2018). https://doi.org/10.1007/s15006-018-1089-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-018-1089-5

Keywords

Search

Navigation